Occult hepatitis B virus infection among Mexican human immunodeficiency virus-1-infected patients

World Journal of Gastroenterology

Volumn 20, Issue 37, 2014, Pages 13530-13537

  Alvarez Muñoz, Ma Teresa ^a   Maldonado Rodriguez, Angelica ^a   Rojas Montes, Othon ^a   Torres Ibarra, Rocio ^b   Gutierrez Escolano, Fernanda ^c   Vazquez Rosales, Guillermo ^a   Gomez, Alejandro ^a   Muñoz, Onofre ^d   Torres, Javier ^a   Lira, Rosalia ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c Hospital General Regional No 72   (Mexico)

^d HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

Author keywords

Hepatitis B surface antigen negative; Hepatitis B virus; Human immunodeficiency virus; Molecular diagnostics; Occult hepatitis B virus infection; Risk factors

Indexed keywords

EMTRICITABINE; LAMIVUDINE; TENOFOVIR; VIRUS DNA; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BIOLOGICAL MARKER; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; MEXICAN; OCCULT HEPATITIS B INFECTION; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD; VIRUS REPLICATION; ADOLESCENT; BLOOD; CHI SQUARE DISTRIBUTION; DRUG COMBINATION; DRUG EFFECTS; GENETICS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MEXICO; MIDDLE AGED; MIXED INFECTION; MOLECULAR DIAGNOSIS; PATHOGENICITY; PREDICTIVE VALUE; PREVALENCE; RISK; RISK FACTOR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; COINFECTION; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MEXICO; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, VIRAL; VIRAL LOAD; YOUNG ADULT;

EID: 84910000198     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i37.13530     Document Type: Article

References (37)

1. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007; 46: 160-170 [PMID: 17112622 DOI: 10.1016/j.jhep.2006.10.007]
2. Raimondo G, Pollicino T, Romanò L, Zanetti AR. A 2010 update on occult hepatitis B infection. Pathol Biol (Paris) 2010; 58: 254-257 [PMID: 20303674 DOI: 10.1016/j.patbio.2010.02.003]
3. Raimondo G , Caccamo G, Filomia R, Pollicino T. Occult HBV infection. Semin Immunopathol 2013; 35: 39-52 [PMID: 22829332 DOI: 10.1007/s00281-012-0327-7]
4. Torbenson M , Thomas DL. Occult hepatitis B. Lancet Infect Dis 2002; 2: 479-486 [PMID: 12150847 DOI: 10.1016/ s1473-3099(02)00345-6]
5. Shire NJ , Rouster SD, Stanford SD, Blackard JT, Martin CM, Fichtenbaum CJ, Sherman KE. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. J Acquir Immune Defic Syndr 2007; 44: 309-314 [PMID: 17159656 DOI: 10.1097/ qai.0b013e31802e29a9]
6. Kazemi-Shirazi L, Petermann D, Müller C. Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C. J Hepatol 2000; 33: 785-790 [PMID: 11097488 DOI: 10.1016/s0168-8278(00)80311-6]
7. Lo Re V , Frank I, Gross R, Dockter J, Linnen JM, Giachetti C, Tebas P, Stern J, Synnestvedt M, Localio AR, Kostman JR, Strom BL. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients. J Acquir Immune Defic Syndr 2007; 44: 315-320 [PMID: 17159655 DOI: 10.1097/qai.0b013e31802ea499]
8. Yuan Q, Ou SH, Chen CR, Ge SX, Pei B, Chen QR, Yan Q, Lin YC, Ni HY, Huang CH, Yeo AE, Shih JW, Zhang J, Xia NS. Molecular characteristics of occult hepatitis B virus from blood donors in southeast China. J Clin Microbiol 2010; 48: 357-362 [PMID: 19940057 DOI: 10.1128/jcm.01781-09]
9. Matsuoka S, Nirei K, Tamura A, Nakamura H, Matsumura H, Oshiro S, Arakawa Y, Yamagami H, Tanaka N, Moriyama M. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C. Intervirology 2008; 51: 352-361 [PMID: 19127078 DOI: 10.1159/000187720]
10. Gilson RJ, Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, McNally T, Kelly GE, Tedder RS, Weller IV. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 1997; 11: 597-606 [PMID: 9108941 DOI: 10.1097/00002030-199705000-00007]
11. Núñez M, Ríos P, Pérez-Olmeda M, Soriano V. Lack of 'occult' hepatitis B virus infection in HIV-infected patients. AIDS 2002; 16: 2099-2101 [PMID: 12370518 DOI: 10.1097/000 02030-200210180-00024]
12. Hofer M, Joller-Jemelka HI, Grob PJ, Lüthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis 1998; 17: 6-13 [PMID: 9512175 DOI: 10.1007/bf01584356]
13. Firnhaber C, Viana R, Reyneke A, Schultze D, Malope B, Maskew M, Di Bisceglie A, MacPhail P, Sanne I, Kew M. Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa. Int J Infect Dis 2009; 13: 488-492 [PMID: 19081280 DOI: 10.1016/j.ijid.2008.08.018]
14. Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. J Med Virol 2009; 81: 406-412 [PMID: 19152393 DOI: 10.1002/jmv.21418]
15. Barth RE, Huijgen Q, Tempelman HA, Mudrikova T, Wensing AM, Hoepelman AI. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa. J Med Virol 2011; 83: 929-934 [PMID: 21503902 DOI: 10.1002/jmv.22026]
16. Raimondo G , Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, Craxì A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky JM, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trépo C, Villa E, Will H, Zanetti AR, Zoulim F. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49: 652-657 [PMID: 18715666 DOI: 10.1016/j.jhep.2008.07.014]
17. García-Montalvo BM, Ventura-Zapata LP. Molecular and serological characterization of occult hepatitis B infection in blood donors from Mexico. Ann Hepatol 2011; 10: 133-141 [PMID: 21502674]
18. Rozanov M, Plikat U, Chappey C, Kochergin A, Tatusova T. A web-based genotyping resource for viral sequences. Nucleic Acids Res 2004; 32: W654-W659 [PMID: 15215470 DOI: 10.1093/nar/gkh419]
19. Roman S, Panduro A. HBV endemicity in Mexico is associated with HBV genotypes H and G. World J Gastroenterol 2013; 19: 5446-5453 [PMID: 24023487 DOI: 10.3748/wjg.v19. i33.5446]
20. Alvarez-Muñoz T, Bustamante-Calvillo E, Martínez-García C, Moreno-Altamirando L, Guiscafre-Gallardo H, Guiscafre JP, Muñoz O. Seroepidemiology of the hepatitis B and delta in the southeast of Chiapas, Mexico. Arch Invest Med (Mex) 1989; 20: 189-195 [PMID: 2604503]
21. Roman S , Panduro A, Aguilar-Gutierrez Y, Maldonado M, Vazquez-Vandyck M, Martinez-Lopez E, Ruiz-Madrigal B, Hernandez-Nazara Z. A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review. Hepatol Int 2009; 3: 343-355 [PMID: 19669360 DOI: 10.1007/s12072-008-9115-9]
22. Bloquel B , Jeulin H, Burty C, Letranchant L, Rabaud C, Venard V. Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort. J Med Virol 2010; 82: 206-212 [PMID: 20029819 DOI: 10.1002/jmv.21685].]
23. Jardim RN , Gonc¸ales NS, Pereira JS, Fais VC, Gonc¸ales Junior FL. Occult hepatitis B virus infection in immunocompromised patients. Braz J Infect Dis 2008; 12: 300-305 [PMID: 19030729 DOI: 10.1590/s1413-86702008000400008]
24. Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. J Med Virol 2009; 81: 441-445 [PMID: 19152397 DOI: 10.1002/jmv.21422]
25. Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. J Med Virol 2007; 79: 1464-1471 [PMID: 17705185 DOI: 10.1002/jmv.20954]
26. Torres-Baranda R , Bastidas-Ramírez BE, Maldonado-González M, Sánchez-Orozco LV, Vázquez-Vals E, Rodrí-guez-Noriega E, Panduro A. Occult hepatitis B in Mexican patients with HIV, an analysis using nested polymerase chain reaction. Ann Hepatol 2006; 5: 34-40 [PMID: 16531963]
27. Aghakhani A , Banifazl M, Kalantar E, Eslamifar A, Ahmadi F, Razeghi E, Atabak S, Amini M, Khadem-Sadegh A, Ramezani A. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study. Ther Apher Dial 2010; 14: 349-353 [PMID: 20609190 DOI: 10.1111/j.1744-9987.2009.00798.x]
28. Azadmanesh K, Mohraz M, Aghakhani A, Edalat R, Jam S, Eslamifar A, Banifazl M, Moradmand-Badie B, Ramezani A. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody. Intervirology 2008; 51: 270-274 [PMID: 18841029 DOI: 10.1159/000160217]
29. Rundell S. Care about care plans! Nurs Times 2010; 87: 32 [PMID: 2020594 DOI: 10.1186/1471-2334-10-53]
30. Ramia S, Mokhbat J, Ramlawi F, El-Zaatari M. Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen. Int J STD AIDS 2008; 19: 197-199 [PMID: 18397562 DOI: 10.1258/ ijsa.2007.007200]
31. Minuk GY, Sun DF, Uhanova J, Zhang M, Caouette S, Nicolle LE, Gutkin A, Doucette K, Martin B, Giulivi A. Occult hepatitis B virus infection in a North American community-based population. J Hepatol 2005; 42: 480-485 [PMID: 15763333]
32. Chen SJ, Zhao YX, Fang Y, Xu WZ, Ma YX, Song ZW, Teng X, Gu HX. Viral deletions among healthy young Chinese adults with occult hepatitis B virus infection. Virus Res 2012; 163: 197-201 [PMID: 21963662 DOI: 10.1016/j.virusres.2011.09.029]
33. Morsica G, Ancarani F, Bagaglio S, Maracci M, Cicconi P, Cozzi Lepri A, Antonucci G, Bruno R, Santantonio T, Tacconi L, Baldelli F, Piscopo R, Santoro D, Lazzarin A, D'Arminio Monforte A. Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features. Infection 2009; 37: 445-449 [PMID: 19669092 DOI: 10.1007/s15010-008-8194-9]
34. Martin CM, Welge JA, Shire NJ, Rouster SD, Shata MT, Sherman KE, Blackard JT. Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals. J Viral Hepat 2010; 17: 588-597 [PMID: 19889143 DOI: 10.1111/j.1365-2893.2009.01214.x]
35. Tsui JI, French AL, Seaberg EC, Augenbraun M, Nowicki M, Peters M, Tien PC. Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women. Clin Infect Dis 2007; 45: 736-740 [PMID: 17712758 DOI: 10.1086/520989]
36. Bagaglio S, Bianchi G, Danise A, Porrino L, Uberti-Foppa C, Lazzarin A, Castagna A, Morsica G. Longitudinal evaluation of occult hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption. Infection 2011; 39: 121-126 [PMID: 21424854 DOI: 10.1007/s15010-011-0093-9]
37. Khamduang W , Ngo-Giang-Huong N, Gaudy-Graffin C, Jourdain G, Suwankornsakul W, Jarupanich T, Chalermpolprapa V, Nanta S, Puarattana-Aroonkorn N, Tonmat S, Lallemant M, Goudeau A, Sirirungsi W. Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women. Clin Infect Dis 2013; 56: 1704-1712 [PMID: 23487379 DOI: 10.1093/cid/cit166]